Who we are and what we are trying to change
Israelis for Ibogaine is a registered Israeli non-profit association — Iboga Bush (R.A.) / סנה איבוגה (ע”ר), registration number 580841922. We exist because Israel is facing a scale of psychological and neurological injury its mental-health system was never built to absorb, and because a body of published research now points to a treatment approach that the country has not yet seriously evaluated. We are not a clinic and we do not provide treatment. We do four things: we educate the public, we work to bring clinical trials into Israeli hospitals, we support academic and biosynthetic research, and we make the policy case for a regulated pathway to access.
Last reviewed:
A National Imperative for Resilience, Recovery, and Brain Repair
Israelis for Ibogaine's mission is to advance public understanding and responsible medical access to ibogaine for PTSD, traumatic brain injuries, addiction, and co-occurring mental health conditions.
We promote scientific research, reduce stigma, and educate the public to accelerate the safe, evidence-based adoption of ibogaine therapy, restoring the cognitive and emotional health of a nation through neuro-regeneration, one mind at a time.
Four Pillars of Action
Israelis for Ibogaine operates across four mutually reinforcing strategic pillars, from public awareness to policy reform, forming a comprehensive national advocacy and research framework.
Public Education
Multi-channel campaigns to de-stigmatise ibogaine, distinguishing it categorically from recreational substances and positioning it as a specialised medical tool.
Clinical Trials
Facilitating and co-funding Phase II/III trials within Israeli hospitals, including Ichilov and Sheba.
Academic & Biosynthetic Research
Supporting the Weizmann Institute and Tel Aviv University's Sagol School to explore ibogaine's biosynthesis.
Policy & Global Safety
Lobbying the MoH for Compassionate Use status and establishing a 'Gold Standard' protocol for safe access.
The Ibogaine Israel Umbrella
Ibogaine Israel is designed to function as the central connective node of a broader national ecosystem, bridging academia, healthcare, civil society, and biotechnology.
Research & Policy
Biosynthetic research, compassionate use and gold-standard protocols
Clinical Trials
Phase II/III trials in Ichilov and Sheba for safety and efficacy
Core Mission
National hub for ibogaine-based brain health reform
Why Israel? Why Now?
The 'Startup Nation' Advantage
Israel is already a global leader in medical cannabis regulation and MDMA-assisted therapy research. The regulatory infrastructure, scientific talent, and institutional appetite are uniquely mature.
An Existential Necessity
With a significant proportion of the civilian workforce and reserve military force impacted by trauma, brain health is national security. An untreated generation represents a compounding threat to Israel's economic productivity, social cohesion, and defensive capacity. The cost of inaction is not abstract. It is strategic.
The Window Is Open — It Will Not Stay Open
"We are not asking Israel to experiment. We are asking Israel to lead as it has done with cannabis, with trauma medicine, and with every other frontier where necessity met scientific courage."
For Policymakers
The science is credible, the precedent is clear, and the patient population is waiting.
For Future Partners
Future partners can help build a regulatory pathway, domestic data infrastructure, and a biosynthetic supply chain intended to serve Israeli patients for decades.
For Health Leaders
Standard care is failing. Ibogaine Israel offers a structured, evidence-driven, safety-first pathway to integrate a proven intervention responsibly and urgently.
Help make ibogaine therapy available in Israel
Add your name to the public petition, or contact us about research collaboration, clinical partnership, volunteering, or media enquiries. We reply to every message.